ZA916618B - Method and compositions for inhibiting aminoglycoside nephrotoxicity - Google Patents

Method and compositions for inhibiting aminoglycoside nephrotoxicity

Info

Publication number
ZA916618B
ZA916618B ZA916618A ZA916618A ZA916618B ZA 916618 B ZA916618 B ZA 916618B ZA 916618 A ZA916618 A ZA 916618A ZA 916618 A ZA916618 A ZA 916618A ZA 916618 B ZA916618 B ZA 916618B
Authority
ZA
South Africa
Prior art keywords
inhibiting
compositions
aminoglycoside nephrotoxicity
nephrotoxicity
aminoglycoside
Prior art date
Application number
ZA916618A
Other languages
English (en)
Inventor
Donald N Mcgregor
N Mcgregor Donald
Thomas J Davidson
J Davidson Thomas
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA916618B publication Critical patent/ZA916618B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polyamides (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA916618A 1990-08-28 1991-08-21 Method and compositions for inhibiting aminoglycoside nephrotoxicity ZA916618B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57418590A 1990-08-28 1990-08-28

Publications (1)

Publication Number Publication Date
ZA916618B true ZA916618B (en) 1992-07-29

Family

ID=24295033

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916618A ZA916618B (en) 1990-08-28 1991-08-21 Method and compositions for inhibiting aminoglycoside nephrotoxicity

Country Status (9)

Country Link
EP (1) EP0473145A1 (xx)
JP (1) JPH04234431A (xx)
KR (1) KR920004404A (xx)
AU (1) AU8270391A (xx)
CA (1) CA2048309A1 (xx)
FI (1) FI914005A (xx)
IE (1) IE913016A1 (xx)
PT (1) PT98783A (xx)
ZA (1) ZA916618B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7345018B2 (en) 2002-04-25 2008-03-18 Reception Aps Method of treating side effects induced by therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526888A (en) * 1983-04-29 1985-07-02 Bristol-Myers Company Nephrotoxicity inhibitors for aminoglycoside antibiotics
CH667874A5 (fr) * 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
US5079234A (en) * 1989-03-23 1992-01-07 Bristol-Myers Squibb Co. Inhibitors of aminoglycoside nephrotoxicity

Also Published As

Publication number Publication date
KR920004404A (ko) 1992-03-27
FI914005A (fi) 1992-02-29
FI914005A0 (fi) 1991-08-23
AU8270391A (en) 1992-03-05
JPH04234431A (ja) 1992-08-24
EP0473145A1 (en) 1992-03-04
CA2048309A1 (en) 1992-03-01
PT98783A (pt) 1992-07-31
IE913016A1 (en) 1992-03-11

Similar Documents

Publication Publication Date Title
EP0448300A3 (en) Method and composition for coiontophoresis
HU9301879D0 (en) Process and compositions for disinfecting contact-lenses
EP0716603A4 (en) METHOD AND COMPOSITION OF THE URIDINE SECRETION
GB9005856D0 (en) Compositions
ZA913515B (en) Algicidally enhanced compositions
EP0616614A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING ELASTASE.
GB9015822D0 (en) Compositions
GB9015892D0 (en) Compositions
ZA916618B (en) Method and compositions for inhibiting aminoglycoside nephrotoxicity
ZA902228B (en) Inhibitors of aminoglycoside nephrotoxicity
EP0448181A3 (en) Interleukin-6 inhibiting compositions
EP0452632A3 (en) Dichloro-pentafluoropropanes-containing compositions
GB9004832D0 (en) Compositions
IE901067L (en) Inhibitors of aminoglycoside nephrotoxicity
GB9016110D0 (en) Cornea-protecting compositions and processes for their production
EP0547140A4 (en) Immunosuppressant composition
HU208481B (en) Mouth-hygienicd compositions
GB9005360D0 (en) Pharmaceutical method and compositions
GB9016349D0 (en) Pharmaceutical method and compositions
GB9005362D0 (en) Pharmaceutical method and compositions
GB9005359D0 (en) Pharmaceutical method and compositions
GB9016348D0 (en) Pharmaceutical method and compositions
GB9005361D0 (en) Pharmaceutical method and compositions
GB9012034D0 (en) Pharmaceutical method and compositions
GB9005358D0 (en) Pharmaceutical method and compositions